Screening and identification of genetic loci involved in producing more/denser inclusion bodies in Escherichia coli
- PMID: 23638724
- PMCID: PMC3668246
- DOI: 10.1186/1475-2859-12-43
Screening and identification of genetic loci involved in producing more/denser inclusion bodies in Escherichia coli
Abstract
Background: Many proteins and peptides have been used in therapeutic or industrial applications. They are often produced in microbial production hosts by fermentation. Robust protein production in the hosts and efficient downstream purification are two critical factors that could significantly reduce cost for microbial protein production by fermentation. Producing proteins/peptides as inclusion bodies in the hosts has the potential to achieve both high titers in fermentation and cost-effective downstream purification. Manipulation of the host cells such as overexpression/deletion of certain genes could lead to producing more and/or denser inclusion bodies. However, there are limited screening methods to help to identify beneficial genetic changes rendering more protein production and/or denser inclusion bodies.
Results: We report development and optimization of a simple density gradient method that can be used for distinguishing and sorting E. coli cells with different buoyant densities. We demonstrate utilization of the method to screen genetic libraries to identify a) expression of glyQS loci on plasmid that increased expression of a peptide of interest as well as the buoyant density of inclusion body producing E. coli cells; and b) deletion of a host gltA gene that increased the buoyant density of the inclusion body produced in the E. coli cells.
Conclusion: A novel density gradient sorting method was developed to screen genetic libraries. Beneficial host genetic changes could be exploited to improve recombinant protein expression as well as downstream protein purification.
Figures







Similar articles
-
Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.Adv Biochem Eng Biotechnol. 2003;85:43-93. doi: 10.1007/3-540-36466-8_3. Adv Biochem Eng Biotechnol. 2003. PMID: 12930093 Review.
-
Revisiting Escherichia coli as microbial factory for enhanced production of human serum albumin.Microb Cell Fact. 2017 Oct 5;16(1):173. doi: 10.1186/s12934-017-0784-8. Microb Cell Fact. 2017. PMID: 28982367 Free PMC article.
-
Expression, Solubilization, Refolding and Final Purification of Recombinant Proteins as Expressed in the form of "Classical Inclusion Bodies" in E. coli.Protein Pept Lett. 2021;28(2):122-130. doi: 10.2174/0929866527999200729182831. Protein Pept Lett. 2021. PMID: 32729411 Review.
-
A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E.Appl Microbiol Biotechnol. 2017 Jul;101(14):5603-5614. doi: 10.1007/s00253-017-8281-x. Epub 2017 Apr 20. Appl Microbiol Biotechnol. 2017. PMID: 28429059 Free PMC article.
-
Inclusion Bodies: Status Quo and Perspectives.Methods Mol Biol. 2023;2617:1-13. doi: 10.1007/978-1-0716-2930-7_1. Methods Mol Biol. 2023. PMID: 36656513
Cited by
-
Recombinant polypeptide production in E. coli: towards a rational approach to improve the yields of functional proteins.Microb Cell Fact. 2013 Nov 1;12:101. doi: 10.1186/1475-2859-12-101. Microb Cell Fact. 2013. PMID: 24176192 Free PMC article. Review.
-
High-yield expression in Escherichia coli, purification and application of budding yeast K2 killer protein.Mol Biotechnol. 2014 Jul;56(7):644-52. doi: 10.1007/s12033-014-9740-6. Mol Biotechnol. 2014. PMID: 24532228
-
Characterization of CpdC, a large-ring lactone-hydrolyzing enzyme from Pseudomonas sp. strain HI-70, and its use as a fusion tag facilitating overproduction of proteins in Escherichia coli.Appl Environ Microbiol. 2013 Nov;79(22):7091-100. doi: 10.1128/AEM.02435-13. Epub 2013 Sep 13. Appl Environ Microbiol. 2013. PMID: 24038681 Free PMC article.
-
Surface patches on recombinant erythropoietin predict protein solubility: engineering proteins to minimise aggregation.BMC Biotechnol. 2019 May 9;19(1):26. doi: 10.1186/s12896-019-0520-z. BMC Biotechnol. 2019. PMID: 31072369 Free PMC article.
References
-
- Brassard DL, Grace MJ, Bordens RW. Interferon-alpha as an immunotherapeutic protein. J Leukoc Biol. 2002;71:565–581. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources